Characterization of a critical role for CFTR chloride channels in cardioprotection against ischemia/reperfusion injury

Acta Pharmacologica Sinica

Volumn 32, Issue 6, 2011, Pages 824-833

  Xiang, Sunny Yang ^a,d   Ye, Linda L ^a   Duan, Li Lu Marie ^a   Liu, Li Hui ^a,c   Ge, Zhi Dong ^b   Auchampach, John A ^b   Gross, Garrett J ^b   Duan, Dayue Darrel ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c Central South University   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

apoptosis; cystic fibrosis transmembrane conductance regulator (CFTR); ischemia; postconditioning; preconditioning

Indexed keywords

CASPASE 3; CHLORIDE CHANNEL; DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; DNA NUCLEOTIDYLEXOTRANSFERASE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; CFTR GENE; CONFERENCE PAPER; CONTROLLED STUDY; EX VIVO STUDY; GENE; GENE INACTIVATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VIVO STUDY; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; KNOCKOUT MOUSE; MALE; MOUSE; NICK END LABELING; NONHUMAN; REPERFUSION INJURY; WILD TYPE;

ANIMALS; APOPTOSIS; CASPASE 3; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE MODELS, ANIMAL; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MICE; MICE, INBRED CFTR; MICE, KNOCKOUT; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PERFUSION;

EID: 79958088887     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2011.61     Document Type: Conference Paper

References (57)

1. Lopez-Neblina F, Toledo AH, Toledo-Pereyra LH. Molecular biology of apoptosis in ischemia and reperfusion. J Invest Surg 2005;18:335-50. (Pubitemid 43123614)
2. Zhao ZQ, Vinten-Johansen J. Myocardial apoptosis and ischemic preconditioning. Cardiovasc Res 2002;55:438-55. (Pubitemid 34874939)
3. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36. (Pubitemid 17174962)
4. Guo Y, Wu WJ, Qiu Y, Tang XL, Yang Z, Bolli R. Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol 1998;275: H1375-87.
5. Ludman AJ, Yellon DM, Hausenloy DJ. Cardiac preconditioning for ischaemia: lost in translation. Dis Model Mech 2010;3:35-8.
6. Ovize M, Baxter GF, Di LF, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, et al. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 2010;87:406-23.
7. Downey JM, Davis AM, Cohen MV. Signaling pathways in ischemic preconditioning. Heart Fail Rev 2007;12:181-8. (Pubitemid 350176691)
8. ATP channels and myocardial preconditioning: an update. Am J Physiol Heart Circ Physiol 2003;285: H921-30. (Pubitemid 37048144)
9. Gross GJ. Selective ATP-sensitive potassium channel openers: fact or fiction. J Mol Cell Cardiol 2003;35:1005-7. (Pubitemid 37083242)
10. Hausenloy DJ, Ong SB, Yellon DM. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol 2009;104:189-202
11. + exchanger is critical to reperfusion damage and preconditioning in the isolated rat heart. Cardiovasc Res 2000;48:244-53.
12. Diaz RJ, Armstrong SC, Batthish M, Backx PH, Ganote CE, Wilson GJ. Enhanced cell volume regulation: a key protective mechanism of ischemic preconditioning in rabbit ventricular myocytes. J Mol Cell Cardiol 2003;35:45-58. (Pubitemid 36286967)
13. Diaz RJ, Losito VA, Mao GD, Ford MK, Backx PH, Wilson GJ. Chloride channel inhibition blocks the protection of ischemic preconditioning and hypo-osmotic stress in rabbit ventricular myocardium. Circ Res 1999;84:763-75. (Pubitemid 29181483)
14. Downey JM, Cohen MV. Why do we still not have cardioprotective drugs? Circ J 2009;73:1171-7.
15. McIntosh VJ, Lasley RD. Adenosine receptor-mediated cardioprotection: are all 4 subtypes required or redundant? J Cardiovasc Pharmacol Ther 2011 doi:10.1177/1074248410396877.
16. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003;285: H579-88. (Pubitemid 36885888)
17. Zhao ZQ, Vinten-Johansen J. Postconditioning: reduction of reperfusioninduced injury. Cardiovasc Res 2006;70:200-11.
18. Gross GJ, Auchampach JA. Reperfusion injury: does it exist? J Mol Cell Cardiol 2007;42:12-8. (Pubitemid 44958622)
19. Philipp S, Yang XM, Cui L, Davis AM, Downey JM, Cohen MV. Post conditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc Res 2006;70:308-14.
20. Heusch G, Buchert A, Feldhaus S, Schulz R. No loss of cardioprotection by postconditioning in connexin 43-deficient mice. Basic Res Cardiol 2006;101:354-6. (Pubitemid 43923392)
21. Skyschally A, van Caster P, Boengler K, Gres P, Musiolik J, Schilawa D, et al. Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res 2009;104:15-8.
22. Peart JN, Headrick JP. Clinical cardioprotection and the value of conditioning responses. Am J Physiol Heart Circ Physiol 2009;296: H1705-20.
23. Heusch G. Postconditioning: old wine in a new bottle? J Am Coll Cardiol 2004;44:1111-2. (Pubitemid 39165148)
24. Burley DS, Baxter GF. Pharmacological targets revealed by myocardial postconditioning. Curr Opin Pharmacol 2009;9:177-88.
25. Granfeldt A, Lefer DJ, Vinten-Johansen J. Protective ischaemia in patients: preconditioning and postconditioning. Cardiovasc Res 2009;83:234-46.
26. Chen H, Liu LL, Ye LL, McGuckin C, Tamowski S, Scowen P, et al. Targeted inactivation of cystic fibrosis transmembrane conductance regulator chloride channel gene prevents ischemic preconditioning in isolated mouse heart. Circulation 2004;110:700-4. (Pubitemid 39056269)
27. Duan D. Phenomics of cardiac chloride channels: the systematic study of chloride channel function in the heart. J Physiol 2009;587:2163-77.
28. Duan DY, Liu LL, Bozeat N, Huang ZM, Xiang SY, Wang GL, et al. Functional role of anion channels in cardiac diseases. Acta Pharmacol Sin 2005;26:265-78. (Pubitemid 40388061)
29. Hume JR, Duan D, Collier ML, Yamazaki J, Horowitz B. Anion transport in heart. Physiol Rev 2000;80:31-81. (Pubitemid 30060561)
30. Sheppard DN, Welsh MJ. Structure and function of the CFTR chloride channel. Physiol Rev 1999;79: S23-S45. (Pubitemid 29058908)
31. Burke MA, Ardehali H. Mitochondrial ATP-binding cassette proteins. Transl Res 2007;150:73-80. (Pubitemid 47081452)
32. Gateau-Roesch O, Argaud L, Ovize M. Mitochondrial permeability transition pore and postconditioning. Cardiovasc Res 2006;70:264-73.
33. ATP-channels in the cardioprotection of preconditioning and postconditioning by sevoflurane in the rat in vivo. Anesth Analg 2005;101:1252-60. (Pubitemid 41531854)
34. Batthish M, Diaz RJ, Zeng HP, Backx PH, Wilson GJ. Pharmacological preconditioning in rabbit myocardium is blocked by chloride channel inhibition. Cardiovasc Res 2002;55:660-71. (Pubitemid 34879092)
35. Diaz RJ, Batthish M, Backx PH, Wilson GJ. Chloride channel inhibition does block the protection of ischemic preconditioning in myocardium. J Mol Cell Cardiol 2001;33:1887-9.
36. Heusch G, Liu GS, Rose J, Cohen MV, Downey JM. No confirmation for a causal role of volume-regulated chloride channels in ischemic preconditioning in rabbits. J Mol Cell Cardiol 2000;32:2279-85. (Pubitemid 32039778)
37. Heusch G, Cohen MV, Downey JM. Ischemic preconditioning through opening of swelling-activated chloride channels? Circ Res 2001;89: E48.
38. Riordan JR, Chang XB. CFTR, a channel with the structure of a transporter. Biochim Biophys Acta 1992;1101:221-2.
39. ATP channels as molecular sensors of cellular meta bo lism. Nature 2006;440:470-6.
40. + channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents. J Gen Physiol 1992;100:573-91.
41. - channels in mammalian cardiac myocytes. Circ Res 1997;81:101-9. (Pubitemid 27272988)
42. - channels in mouse heart: a novel, alternative pathway for CFTR regulation. J Physiol (Lond) 1999;521:43-56.
43. 2+ release in HepG2 human hepatoblastoma cells. Biochem Biophys Res Commun 1999;261:682-8. (Pubitemid 29408118)
44. - channels in HepG2 human hepatoblastoma cells. J Cell Biochem 2001;81:93-101.
45. Xu Y, Krause A, Hamai H, Harvey BG, Worgall TS, Worgall S. Proin flamma tory phenotype and increased caveolin-1 in alveolar macrophages with silenced CFTR mRNA. PLoS One 2010;5: e11004.
46. Valverde MA, Vazquez E, Munoz FJ, Nobles M, Delaney SJ, Wainwright BJ, et al. Murine CFTR channel and its role in regulatory volume decrease of small intestine crypts. Cell Physiol Biochem 2000;10:321-8. (Pubitemid 32008915)
47. L'hoste S, Chargui A, Belfodil R, Corcelle E, Duranton C, Rubera I, et al. CFTR mediates apoptotic volume decrease and cell death by controlling glutathione efflux and ROS production in cultured mice proximal tubules. Am J Physiol Renal Physiol 2010;298: F435-53.
48. Barriere H, Poujeol C, Tauc M, Blasi JM, Counillon L, Poujeol P. CFTR modulates programmed cell death by decreasing intracellular pH in Chinese hamster lung fibroblasts. Am J Physiol Cell Physiol 2001;281: C810-24.
49. L'hoste S, Chargui A, Belfodil R, Duranton C, Rubera I, Mograbi B, et al. CFTR mediates cadmium-induced apoptosis through modulation of ROS level in mouse proximal tubule cells. Free Radic Biol Med 2009;46:1017-31.
50. Thevenod F. Multifaceted CFTR: novel role in ROS signaling and apoptotic cell death - a commentary on "CFTR mediates cadmiuminduced apoptosis through modulation of ROS levels in mouse proximal tubule cells". Free Radic Biol Med 2009;46:1014-6.
51. Yalcin E, Talim B, Ozcelik U, Dogru D, Cobanoglu N, Pekcan S, et al. Does defective apoptosis play a role in cystic fibrosis lung disease? Arch Med Res 2009;40:561-4.
52. Ruiz PE, Ponce ZA, Schanne OF. Early action potential shortening in hypoxic hearts: role of chloride current (s) mediated by catecholamine release. J Mol Cell Cardiol 1996;28:279-90. (Pubitemid 26110472)
53. Boujaoude LC, Bradshaw-Wilder C, Mao C, Cohn J, Ogretmen B, Hannun YA, et al. Cystic fibrosis transmembrane regulator regulates uptake of sphingoid base phosphates and lysophosphatidic acid: modulation of cellular activity of sphingosine 1-phosphate. J Biol Chem 2001;276:35258-64.
54. Karliner JS. Lysophospholipids and the cardiovascular system. Biochim Biophys Acta 2002;1582:216-21. (Pubitemid 34634132)
55. Kunzelmann K. CFTR: interacting with everything? News Physiol Sci 2001;16:167-70. (Pubitemid 33713264)
56. Guggino WB, Stanton BA. New insights into cystic fibrosis: molecular switches that regulate CFTR. Nat Rev Mol Cell Biol 2006;7:426-36. (Pubitemid 44050096)
57. Wang X, Venable J, LaPointe P, Hutt DM, Koulov AV, Coppinger J, et al. Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 2006;127:803-15. (Pubitemid 44716255)